Maki Nakamura

Risk factors for cisplatin-induced acute kidney injury: A pilot study on the usefulness of genetic variants for predicting nephrotoxicity in clinical practice

Y. Nishimura, Kanako Saito, M. Ikejiri, 2020, Molecular and clinical oncology.

MPL exon 10 mutations other than canonical MPL W515L/K mutations identified by in-house MPL exon 10 direct sequencing in essential thrombocythemia

Y. Sugimoto, M. Ikejiri, K. Nakatani, 2021, International Journal of Hematology.

Cancer-associated gene analysis of cervical cytology samples and liquid-based cytology significantly improve endometrial cancer diagnosis sensitivity

Y. Okugawa, K. Nakatani, H. Imai, 2022, Oncology letters.

High prevalence of congenital thrombophilia in patients with pregnancy-related or idiopathic venous thromboembolism/pulmonary embolism

T. Ikeda, M. Ikejiri, K. Nakatani, 2017, International Journal of Hematology.